K. Horiuchi

发表

Radioiodinated 2'-iodospiperone: a new radioligand for in vivo dopamine receptor study.

H. Saji, K. Torizuka, A. Yoshitake, 1987, Life sciences.

Susceptibility to Cold in Newborns of Levodopa-treated Rats

K. Horiuchi, I. Mena, G. López, 1972, Nature.

Carrier effect on radiolabeling the polynuclear pentavalent rhenium-186 complex of dimercaptosuccinic acid at alkaline pH: 186Re(V)-DMS.

H. Saji, A. Yokoyama, K. Horiuchi, 1999, Nuclear medicine and biology.

Tc(V)-DMS tumor localization mechanism: a pH-sensitive Tc(V)-DMS-enhanced target/nontarget ratio by glucose-mediated acidosis.

H. Saji, A. Yokoyama, K. Horiuchi, 1998, Nuclear medicine and biology.

pH sensitive properties of Tc(V)-DMS: analytical and in vitro cellular studies.

H. Saji, A. Yokoyama, K. Horiuchi, 1998, Nuclear medicine and biology.

Procurement of radioiodinated glucose derivative and its biological character.

Y. Magata, H. Saji, K. Torizuka, 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

62Zn-EDDA: a radiopharmaceutical for pancreatic functional diagnosis.

Y. Fujibayashi, H. Saji, K. Torizuka, 1986, International journal of nuclear medicine and biology.

The integrity of the disulfide bond in a cyclic somatostatin analog during 99mTc complexation reactions.

H. Saji, N. Fujii, K. Ogawa, 1999, Nuclear Medicine and Biology.

Technetium-99m-labeled monoclonal antibody with preserved immunoreactivity and high in vivo stability.

H. Sakahara, H. Saji, M. Koizumi, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Iron(III)-nitrilotriacetate: an agent for reducing the time interval of tumor imaging with gallium citrate.

K. Yamamoto, H. Saji, K. Torizuka, 1985, International journal of nuclear medicine and biology.

Synthesis and evaluation of a new bifunctional chelating agent for 99mTc labeling proteins: p-carboxyethylphenylglyoxal-di(N-methylthiosemicarbazone).

Y. Magata, H. Saji, K. Torizuka, 1986, International journal of nuclear medicine and biology.

Plasma protein binding of (99m)Tc-labeled hydrazino nicotinamide derivatized polypeptides and peptides.

T. Saga, J. Konishi, H. Saji, 2001, Nuclear medicine and biology.

In the procurement of stable 99mTc labeled protein using bifunctional chelating agent.

Y. Magata, H. Saji, K. Torizuka, 1986, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[125I] Radioiodinated metaraminol: a new platelet-specific labeling agent

H. Saji, K. Torizuka, A. Yokoyama, 2004, European Journal of Nuclear Medicine.

Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication.

K. Yamamoto, Y. Ishii, H. Saji, 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The development of (99m)Tc-analog of Cu-DTS as an agent for imaging hypoxia.

Y. Fujibayashi, H. Saji, M. Nakayama, 2000, Nuclear medicine and biology.

Design of bifunctional radiopharmaceutical for the development of 99mTc complexes for myocardial imaging agents.

H. Saji, K. Torizuka, A. Yokoyama, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Imaging of Head and Neck Tumors with Technetium(V)-99m DMSA A New Tumor-Seeking Agent

H. Sakahara, T. Fujita, K. Torizuka, 1985, Clinical nuclear medicine.

Imaging of Soft Tissue Tumors with Tc(V)-99m Dimercaptosuccinic Acid: A New Tumor-seeking Agent

H. Sakahara, T. Fujita, K. Torizuka, 1984, Clinical nuclear medicine.

99Tcm chemical state in 99Tcm labeled radiopharmaceuticals--I. Preparation and biological behavior of 99Tcm-penicillamine complex with a low hydrolyzed 99Tcm state.

H. Saji, K. Torizuka, A. Yokoyama, 1978, International journal of nuclear medicine and biology.

In vivo kinetics and thrombus accumulation of 67Ga-labeled urokinase.

H. Saji, K. Torizuka, A. Yokoyama, 1985, International journal of nuclear medicine and biology.

Technetium-99m-kethoxal-bis(thiosemicarbazone), an uncharged complex with a tetravalent 99mTc state, and its excretion into the bile.

A. Yokoyama, K. Horiuchi, Y. Terauchi, 1976, Journal of Nuclear Medicine.

Mononuclear and dinuclear complexes of 99mTc.

A. Yokoyama, K. Horiuchi, 1982, The International journal of applied radiation and isotopes.

Search for polynuclear pentavalent technetium complex of dimercaptosuccinic acid [Tc(V)-DMS] tumour localization mechanism

A. Yokoyama, K. Endo, K. Horiuchi, 1991, European Journal of Nuclear Medicine.

Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.

T. Fujita, J. Konishi, K. Torizuka, 1988, Nuclear medicine communications.

Technetium coordination state as a factor of stability in 99mTc-complexes used in hepatobiliary system: Comparative studies on 99mTc-complexes of pyridoxal with glutamate (Tc-PG) and isoleucine (Tc-PI)

H. Saji, K. Torizuka, A. Yokoyama, 1981, European Journal of Nuclear Medicine.

Analysis of 99mTc-pyridoxylidene-glutamate complex formation and its preparation with tin-adsorbed-resin: Sn-resin kit method

H. Saji, K. Torizuka, A. Yokoyama, 1981, European Journal of Nuclear Medicine.

In the procurement of a neutral and compact monomeric complex of dithiosemicarbazone (DTS) derivative: 99mTc-KTS.

H. Saji, K. Torizuka, A. Yokoyama, 1986, International journal of nuclear medicine and biology.

Tin-absorbed resin for the preparation of 99mTc-radiopharmaceuticals: stable complex of 99mTc-bleomycin.

Y. Fujibayashi, K. Torizuka, A. Yokoyama, 1981, The International journal of applied radiation and isotopes.

The importance of the chemical state of 99mTc radiopharmaceuticals: an effective tumor imaging form of 99mTc bleomycin.

K. Torizuka, A. Yokoyama, R. Morita, 1978, The International journal of applied radiation and isotopes.

The design of a pentavalent 99mTc-dimercaptosuccinate complex as a tumor imaging agent.

K. Yamamoto, H. Saji, K. Torizuka, 1985, International journal of nuclear medicine and biology.

Images of Liposarcoma Using Technetium-99m Bleomycin and Technetium (V)-99m DMSA

K. Torizuka, A. Yokoyama, K. Endo, 1986, Clinical nuclear medicine.

A Comparison of the Tumor-seeking Agent Tc-99m(V) Dimercaptosuccinic Acid and the Renal Imaging Agent Tc-99m Dimercaptosuccinic Acid in Humans

H. Sakahara, K. Torizuka, A. Yokoyama, 1985, Clinical nuclear medicine.

Ligandin binding phthalein complexone complex of technetium for hepatic function studies

H. Saji, A. Yokoyama, Y. Arano, 2005, European Journal of Nuclear Medicine.

67Ga-labeled human fibrinogen: A new promising thrombus imaging agent

Y. Ishii, Kazutaka Yamamoto, K. Torizuka, 2004, European Journal of Nuclear Medicine.